These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 33178392)

  • 41. The Therapeutic Significance of Mesenchymal Stem Cells in COVID-19 Acute Pulmonary Respiratory Disease.
    Kançağı DD; Ovalı E
    Turk Thorac J; 2022 Sep; 23(5):355-363. PubMed ID: 35943071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies.
    Kaffash Farkhad N; Reihani H; Sedaghat A; Moghadam AA; Moghadam AB; Tavakol-Afshari J
    Regen Ther; 2021 Dec; 18():152-160. PubMed ID: 34124322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Taming of Covid-19: potential and emerging application of mesenchymal stem cells.
    Najafi-Ghalehlou N; Roudkenar MH; Langerodi HZ; Roushandeh AM
    Cytotechnology; 2021 Apr; 73(2):253-298. PubMed ID: 33776206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mesenchymal Stem Cells and COVID-19: Cure, Prevention, and Vaccination.
    Afarid M; Sanie-Jahromi F
    Stem Cells Int; 2021; 2021():6666370. PubMed ID: 34035820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID 19 and diabetes: An endocrinologist's perspective.
    Behera KK; Hota D; Mahapatra A
    J Family Med Prim Care; 2020 Sep; 9(9):4512-4515. PubMed ID: 33209754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulatory T cells in COVID-19.
    Wang H; Wang Z; Cao W; Wu Q; Yuan Y; Zhang X
    Aging Dis; 2021 Oct; 12(7):1545-1553. PubMed ID: 34631206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human menstrual blood-derived stem cells as immunoregulatory therapy in COVID-19: A case report and review of the literature.
    Lu J; Xie ZY; Zhu DH; Li LJ
    World J Clin Cases; 2021 Mar; 9(7):1705-1713. PubMed ID: 33728315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?
    Zizzo G; Cohen PL
    Lancet Rheumatol; 2020 Dec; 2(12):e779-e790. PubMed ID: 33073244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-CoV-2: the "Uncensored" Truth about Its Origin and Adipose-Derived Mesenchymal Stem Cells as New Potential Immune-Modulatory Weapon.
    Gentile P
    Aging Dis; 2021 Apr; 12(2):330-344. PubMed ID: 33815867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Poly(I:C) enhances mesenchymal stem cell control of myeloid cells from COVID-19 patients.
    Souza-Moreira L; Tan Y; Wang Y; Wang JP; Salkhordeh M; Virgo J; Florian M; Murray ABP; Watpool I; McIntyre L; English S; Stewart DJ; Mei SHJ
    iScience; 2022 May; 25(5):104188. PubMed ID: 35402859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet lysate for COVID-19 pneumonia-a newer adjunctive therapeutic avenue.
    Jeyaraman M; Muthu S; Khanna M; Jain R; Anudeep TC; Muthukanagaraj P; Siddesh SE; Gulati A; Satish AS; Jeyaraman N; Khanna V
    Stem Cell Investig; 2021; 8():11. PubMed ID: 34268440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modeling and simulations of CoViD-19 molecular mechanism induced by cytokines storm during SARS-CoV2 infection.
    Yu Z; Ellahi R; Nutini A; Sohail A; Sait SM
    J Mol Liq; 2021 Apr; 327():114863. PubMed ID: 33281252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compartmentalization of the inflammatory response during bacterial sepsis and severe COVID-19.
    Cavaillon JM; Chousterman BG; Skirecki T
    J Intensive Med; 2024 Jul; 4(3):326-340. PubMed ID: 39035623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of Biomarkers in Hospitalized COVID-19 Patients With Systemic Manifestations.
    Schneider M
    Biomark Insights; 2022; 17():11772719221108909. PubMed ID: 35783222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report.
    Salamoon M; Kenj M
    Memo; 2022; 15(2):149-152. PubMed ID: 34149939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mesenchymal Stem Cells Represent a Potential Therapeutic Option for Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome.
    Zhao X; Zhang Y
    Engineering (Beijing); 2020 Oct; 6(10):1073-1075. PubMed ID: 32837745
    [No Abstract]   [Full Text] [Related]  

  • 57. N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome.
    Assimakopoulos SF; Marangos M
    Med Hypotheses; 2020 Apr; 140():109778. PubMed ID: 32344315
    [No Abstract]   [Full Text] [Related]  

  • 58. Editorial: A Compendium of Recent Research on Stem Cell-Based Therapy for Covid-19.
    Hmadcha A; Soria B; Zhao RC; Smani T; Valverde I
    Front Cell Dev Biol; 2021; 9():813384. PubMed ID: 34970555
    [No Abstract]   [Full Text] [Related]  

  • 59. Erratum: Severe Acute Kidney Injury in Patients with COVID-19 and Acute Respiratory Distress Syndrome.
    Am J Respir Crit Care Med; 2021 Jan; 203(1):151. PubMed ID: 33385221
    [No Abstract]   [Full Text] [Related]  

  • 60. COVID-19: is fibrosis the killer?
    Leask A
    J Cell Commun Signal; 2020 Jun; 14(2):255. PubMed ID: 32406037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.